Expansion of functional personalized cells with specific transgene combinations

Fundamental research and drug development for personalized medicine necessitates cell cultures from defined genetic backgrounds. However, providing sufficient numbers of authentic cells from individuals poses a challenge. Here, we present a new strategy for rapid cell expansion that overcomes curren...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 9; no. 1; pp. 994 - 12
Main Authors Lipps, Christoph, Klein, Franziska, Wahlicht, Tom, Seiffert, Virginia, Butueva, Milada, Zauers, Jeannette, Truschel, Theresa, Luckner, Martin, Köster, Mario, MacLeod, Roderick, Pezoldt, Jörn, Hühn, Jochen, Yuan, Qinggong, Müller, Peter Paul, Kempf, Henning, Zweigerdt, Robert, Dittrich-Breiholz, Oliver, Pufe, Thomas, Beckmann, Rainer, Drescher, Wolf, Riancho, Jose, Sañudo, Carolina, Korff, Thomas, Opalka, Bertram, Rebmann, Vera, Göthert, Joachim R., Alves, Paula M., Ott, Michael, Schucht, Roland, Hauser, Hansjörg, Wirth, Dagmar, May, Tobias
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.03.2018
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fundamental research and drug development for personalized medicine necessitates cell cultures from defined genetic backgrounds. However, providing sufficient numbers of authentic cells from individuals poses a challenge. Here, we present a new strategy for rapid cell expansion that overcomes current limitations. Using a small gene library, we expanded primary cells from different tissues, donors, and species. Cell-type-specific regimens that allow the reproducible creation of cell lines were identified. In depth characterization of a series of endothelial and hepatocytic cell lines confirmed phenotypic stability and functionality. Applying this technology enables rapid, efficient, and reliable production of unlimited numbers of personalized cells. As such, these cell systems support mechanistic studies, epidemiological research, and tailored drug development. Personalised medicine requires cell cultures from defined genetic backgrounds, but providing sufficient numbers of cells is a challenge. Here the authors develop gene cocktails to expand primary cells from a variety of different tissues and species, and show that expanded endothelial and hepatic cells retain properties of the differentiated phenotype.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-018-03408-4